Show simple item record

dc.contributor.authorGómez Zorita, Saioa
dc.contributor.authorMilton Laskibar, Iñaki
dc.contributor.authorGarcía Arellano, Laura
dc.contributor.authorGonzález, Marcela
dc.contributor.authorPortillo Baquedano, María Puy ORCID
dc.date.accessioned2021-08-09T08:58:30Z
dc.date.available2021-08-09T08:58:30Z
dc.date.issued2021-07-26
dc.identifier.citationInternational Journal of Molecular Sciences 22(15) : (2021) // Article ID 7975es_ES
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/10810/52782
dc.description.abstractThe present review is aimed at analysing the current evidence concerning the potential modulation of obesity and/or diet in adipose tissue ACE2. Additionally, the potential implications of these effects on COVID-19 are also addressed. The results published show that diet and obesity are two factors that effectively influence the expression of Ace2 gene in adipose tissue. However, the shifts in this gene do not always occur in the same direction, nor with the same intensity. Additionally, there is no consensus regarding the implications of increased adipose tissue ACE2 expression in health. Thus, while in some studies a protective role is attributed to ACE2 overexpression, other studies suggest otherwise. Similarly, there is much debate regarding the role played by ACE2 in COVID-19 in terms of degree of infection and disease outcomes. The greater risk of infection that may hypothetically derive from enhanced ACE2 expression is not clear since the functionality of the enzyme seems to be as important as the abundance. Thus, the greater abundance of ACE2 in adipose tissue of obese subjects may be counterbalanced by its lower activation. In addition, a protective role of ACE2 overexpression has also been suggested, associated with the increase in anti-inflammatory factors that it may produce.es_ES
dc.description.sponsorshipThis research was funded by the University of the Basque Country under Grant GIU18-173 and CIBEROBN under Grant CB12/03/30007.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjectSARS-CoV-2 infectiones_ES
dc.subjectCOVID-19es_ES
dc.subjectadipose tissuees_ES
dc.subjectobesityes_ES
dc.subjectdiet compositiones_ES
dc.subjectcaloric restrictiones_ES
dc.subjectACE2es_ES
dc.subjectrenin–angiotensin systemes_ES
dc.titleAn Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2021-08-06T15:19:13Z
dc.rights.holder2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/22/15/7975/htmes_ES
dc.identifier.doi10.3390/ijms22157975
dc.departamentoesFarmacia y ciencias de los alimentos
dc.departamentoeuFarmazia eta elikagaien zientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).